Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Etfmg Treatments Testing and Advancements ETF (GERM)

Etfmg Treatments Testing and Advancements ETF (GERM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family ETF Managers Group
  • Assets Under Management 61,129,700
  • Shares Outstanding, K 1,550
  • 60-Month Beta 1.98
Trade GERM with:
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 0.29 (0.72%)
  • Most Recent Dividend 0.285 on 12/14/20
  • Management Fee 0.68%
  • Sectors:

Options Overview

Details
  • Implied Volatility 29.48%
  • Historical Volatility 23.76%
  • IV Percentile 11%
  • IV Rank 26.50%
  • IV High 92.81% on 01/27/21
  • IV Low 6.65% on 05/26/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 7
  • Put/Call OI Ratio 0.05
  • Today's Open Interest 370
  • Open Int (30-Day) 306

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.39 +9.64%
on 05/19/21
40.35 -3.84%
on 06/10/21
+2.59 (+7.15%)
since 05/14/21
3-Month
33.40 +16.17%
on 03/29/21
40.35 -3.84%
on 06/10/21
+1.81 (+4.89%)
since 03/15/21

Most Recent Stories

More News
ETFs to Win as Moderna Seeks COVID-19 Vaccine Nod for Teens

Moderna (MRNA) is once again in the spotlight with an impressive update relating to mRNA-1273.

MRNA : 201.34 (-2.93%)
IBB : 159.36 (-1.53%)
BBH : 194.51 (-1.71%)
IDNA : 48.50 (-2.18%)
GERM : 38.80 (-1.62%)
5 Sector ETFs That Crushed the Market in April

April proved to be the solid month for the U.S. stock market with all the three major indices hovering near record highs.

SLX : 62.85 (-1.58%)
COPX : 37.51 (-5.06%)
AMZA : 31.31 (-1.07%)
VCLO : 12.21 (-1.61%)
GERM : 38.80 (-1.62%)
Novavax Vaccine to Get U.S. Approval? ETFs to Benefit

Novavax (NVAX) is reportedly set to receive the fourth authorization for COVID-19 vaccine in the United States.

JNJ : 164.86 (-0.31%)
AZN : 58.67 (-0.15%)
NVAX : 189.28 (-8.87%)
IBB : 159.36 (-1.53%)
XBI : 133.60 (-2.25%)
BBH : 194.51 (-1.71%)
VIRS : 30.95 (+0.05%)
BUZZ : 25.30 (-1.98%)
GERM : 38.80 (-1.62%)
5 Niche ETFs Dominating the Current Market Rally

We have highlighted five ETFs from different zones that were at the heart of the latest market rally over the past week and will likely to do so if the current trends prevail.

COPX : 37.51 (-5.06%)
SGDJ : 48.00 (-1.67%)
LIT : 69.29 (-1.17%)
REMX : 81.30 (-3.74%)
GERM : 38.80 (-1.62%)
Top-Performing ETFs of Last Week

Last week was upbeat for Wall Street with the S&P 500 and the Dow Jones closing out at a record high.

COPX : 37.51 (-5.06%)
SGG : 53.52 (-1.25%)
UNG : 11.40 (-3.47%)
BDRY : 28.80 (+6.67%)
GERM : 38.80 (-1.62%)
Moderna ETFs to Gain on Positive 'Real-World' Study Data

Positive coronavirus vaccine progress by Moderna (MRNA) grabs investors' attention.

PFE : 39.57 (-0.15%)
MRNA : 201.34 (-2.93%)
IBB : 159.36 (-1.53%)
BBH : 194.51 (-1.71%)
BTEC : 58.64 (-2.22%)
GERM : 38.80 (-1.62%)
What's in Store for COVID-Themed ETFs as New Cases Rise?

The first half of 2021 is expected to continue bearing the brunt of the coronavirus outbreak considering the pandemic's renewed resurgence thanks to variants. Thus, a COVID-themed ETF could be a smart...

WFH : 74.27 (-0.97%)
VIRS : 30.95 (+0.05%)
EDUT : 14.53 (-0.55%)
EDOC : 18.66 (-1.27%)
GERM : 38.80 (-1.62%)
Novavax ETFs to Shine Bright on Positive Vaccine Update

Investors are closely tracking the progress in coronavirus vaccine development and distribution amid the pandemic.

JNJ : 164.86 (-0.31%)
NVAX : 189.28 (-8.87%)
IBB : 159.36 (-1.53%)
XBI : 133.60 (-2.25%)
BBH : 194.51 (-1.71%)
GERM : 38.80 (-1.62%)
6 ETF Areas That Are on High Momentum

The first month of 2021 was pretty volatile. While stocks were at their all-time highs in first part of January, some downbeat economic data points as well as the retail trading frenzy in some specific...

IWM : 230.17 (-0.37%)
SLVP : 17.16 (-2.64%)
SILJ : 16.83 (-2.94%)
DJP : 26.88 (-1.29%)
GAZ : 17.73 (-2.82%)
VPN : 17.47 (-0.66%)
GERM : 38.80 (-1.62%)
5 Sector ETFs That Outperformed in a Volatile January

The three indices logged in their worst week since October, dropping more than 3% each, sending the Dow Jones and S&P 500 into the red for the first month of 2021.

GME : 211.10 (-7.99%)
XRT : 94.14 (-1.76%)
AMC : 58.82 (+3.19%)
PRNT : 37.68 (-1.13%)
GAMR : 97.99 (-0.51%)
POTX : 14.48 (-2.85%)
GERM : 38.80 (-1.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The ETFMG Treatments Testing and Advancements ETF seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the Prime Treatments, Testing and Advancements Index.

See More

Key Turning Points

3rd Resistance Point 40.86
2nd Resistance Point 40.47
1st Resistance Point 39.95
Last Price 38.80
1st Support Level 39.05
2nd Support Level 38.66
3rd Support Level 38.14

See More

Last Price 38.80
52-Week High N/A
Fibonacci 61.8% 36.71
Fibonacci 50% 34.24
Fibonacci 38.2% 31.78
52-Week Low N/A

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar